solid finish strong prospect
ajg adjust ep per share forecast consensu
bulk upsid per share forecast came corpor
segment although earn brokerag risk manag segment
penni project brokerag organ growth risk
manag forecast
commiss fee organ growth brokerag segment beat
forecast organ growth volatil quarterli howev base current trend
manag confer call commentari regard market condit
compani initi rais forward assumpt look
organ growth next year previous forecast
assum rel modest margin improv
rais estim
rais estim project
increas due higher organ growth rate assumpt
higher expect earn corpor segment narrow margin
improv assumpt slightli reflect higher incent base compens
expect continu model ebitdac margin risk
manag oper expect reacceler growth segment
manag provid rang assumpt corpor segment
build previous incorpor lower tax rate due
chang tax law manag assumpt consist model
rais po dividend yield averag
rais price object due higher estim
modestli higher multipl price object cash ep estim
previous confid ajg growth prospect given recent
trend support expand multipl multipl discount peer
reflect execut risk given gallagh aggress strategi support
expect double-digit ep growth next sever year dividend
yield provid addit support reiter buy rate
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
arthur gallagh world fourth-largest
risk manag servic via network
subsidiari place p/c reinsur surplu
line manag employe benefit program
risk manag servic perform
manag loss control consult worker
believ one best-run middle-
market insur broker organ growth
respond better price econom
environ growth along good
expens disciplin allow continu
margin improv acquisit remain
attract avenu growth above-averag
dividend yield attract sustain
modest beat trend support thesi
ajg adjust ep per share forecast consensu
bulk upsid per share forecast came corpor
segment although earn brokerag risk manag segment
penni project brokerag organ growth risk
manag growth forecast compani take
million charg incur million cost associ tax law
chang item includ oper incom
commiss fee organ growth brokerag segment beat
forecast organ growth volatil quarterli howev base current trend
manag confer call commentari regard market condit
compani initi rais forward assumpt look
organ growth next year previous rel
modest forecast assum rel modest margin improv
assum compani continu activ acquir
believ growth larg come new busi win good
retent rather lift price econom growth improv
price would modest boost appear chanc posit chang
increas follow catastroph loss better econom environ
would help corpor revenu headcount import input premium
growth compani appear well-posit benefit stimulu us
economi increas inflat organ growth may prove
risk manag organ growth better expect organ
growth limit law chang south australia time
expect variabl figur expect growth reemerg somewhat go
forward ebitdac margin run near year date healthi figur
expect compani abl maintain
acquisit activ remain import
compani close deal fourth quarter annual revenu
million full year compani close deal million
acquir annual revenu compani complet deal
million annual revenu expect acquisit continu
import contributor growth earn assum somewhat acceler
avenu growth although assumpt remain
histor high valuat ajg target acquisit remain fairli consist although
could rise slightli due tax reform
view sum total ajg results/act favor strateg
financi perspect acquir revenu may consid less valuabl
investor organ growth given natur ajg busi continu
compani ad revenu base acquisit
year view acquir growth favor acquisit continu build
ajg grow global presenc even model new share issu part
 strategi appear accret earn
expect compani continu acquir smaller oper steadi pace
pipelin appear remain quit healthi continu see ajg acquisit
strategi on-going aspect buy rate view growth potenti
bigger platform canada australia uk provid opportun grow
strong track record due dilig integr view smart
acquir believ manag skill resourc effect integr
compani senior manag acquir compani typic remain
compani done effect job due dilig ahead acquisit
ensur cultur strateg fit although intim familiar
busi compani acquir almost smaller privat compani ajg
strong track record provid us confid abil digest
rais estim
rais estim project
increas due higher organ growth rate assumpt
higher expect earn corpor segment narrow margin
improv assumpt slightli reflect higher incent base compens
expect due stronger organ growth project continu model
ebitdac margin risk manag oper consist
manag outlook expect reacceler growth segment
manag provid rang assumpt corpor segment
build previous incorpor lower tax rate due
chang tax law manag assumpt consist
chang revenu recognit could aid result slightli forward earn
season impact chang revenu recognit model
chang yet sever chang impact quarterli pattern
earn manag note absolut basi revenu earn
brokerag segment aid chang reassess impact upon
disclosur compani first quarter
rais po dividend yield averag
rais price object due higher estim
modestli higher multipl price object cash ep estim
previous confid ajg growth prospect given
recent trend support expand multipl multipl discount peer
reflect execut risk given gallagh aggress strategi
support expect double-digit ep growth next sever year
invest incom
gain book sale
chang acquisit earn out/oth
earn incom tax
provis incom tax
organ growth
earn incom tax
provis incom tax
organ growth fee
bofa merril lynch global research compani document
estimate
earn incom tax
provis incom tax
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research compani document
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
organ growth
earn incom tax
provis incom tax
organ growth fee
bofa merril lynch global research compani document
invest incom
chang acquisit earn out/oth
earn incom tax
provis incom tax
bofa merril lynch global research compani document
price object cash ep estim multipl discount
peer reflect execut risk given gallagh aggress strategi
support expect double-digit ep growth next sever
year dividend yield provid addit support downsid risk price
object softer property-casualty price built expect
poor integr one sever acquisit lower industry-wid claim frequenc
hurt claim manag busi rise unemploy could hurt
claim manag busi expos worker compens residu
environment tax liabil relat synthet coal invest chang
health care regul impact benefit broke busi chang
dividend strategi compani
alison jacobowitz herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us properti casualti insur coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
